HypoxiaNCT00731510
MEDEX Hidden Valley 2008
A study testing Carbohydrate energy drink and Aspartame in people with Hypoxia, run by Medical Expeditions Ltd at 1 site in United Kingdom.
Trial summary
During a multi-week expedition to the Himalaya, we aim to investigate i) whether dietary supplementation with carbohydrate drinks and gels can improve physical performance; and ii) the underlying mechanisms for any observed changes in performance. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Hypoxia
- What is being tested?
- Carbohydrate energy drink and Aspartame
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 44 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- Jun 2008to Dec 2008
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- a healthy enthusiasm for the outdoors and/or a passion for research in remote and difficult circumstances
Who cannot join
- Persons with Phenylketonuria
Trial locations and contacts
1 site in 1 country.
United Kingdom1 site
Medical Expeditions Ltd
Pinfold, Hyssington, Montgomery, Powys, SY15 6AY
About this study
During a multi-week expedition to the Himalaya, we aim to investigate i) whether dietary supplementation with carbohydrate drinks and gels can improve physical performance; and ii) the underlying mechanisms for any observed changes in performance.
We hypothesise that i) carbohydrate supplementation will improve physical performance; and ii) the underlying mechanism of this improvement in performance will include maintenance of body glycogen (sugar) stores, prevention of dehydration and decrease in the incidence of acute mountain sickness.
- Conditions
- Hypoxia
- Being tested
- Carbohydrate energy drink, Aspartame
- Keywords
- Acute mountain sickness, Body composition,Hypoxia, Carbohydrate supplementation, Expedition,, Hydration,, Hypoxia, Performance
- Medical subject headings
- Hypoxia, Altitude Sickness
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Carbohydrate energy drinkDietary supplement
Also called PSP22 Energy, Science in Sport, Blackburn, UK
Complex carbohydrates including maltodextrin (97%) dissolved in water to make a a 10% solution, or dissolved in 25mL gels. Ad libitum. Twenty two days.
AspartameDietary supplement
Also called Science in Sport, Blackburn, UK
Aspartame dissolved in water, ad libitum, 22 days.
| Study group | Role | What they receive |
|---|---|---|
| 1 | Experimental | Carbohydrate supplements (drinks and gels) Receives: Dietary Supplement: Carbohydrate energy drink |
| 2 | Placebo comparator | Primarily Aspartame plus natural flavourings. Powder dissolved in water to provide non-distinguishable placebo drink. Receives: Dietary Supplement: Aspartame |
What is being measured
The primary outcome is the main question the study is designed to answer.
Performance (time to complete a physical performance task)
Measured: Mid study
Secondary outcomes (7)
Body composition
Measured: Pre, mid and post study
Hydration status
Measured: Pre, mid and post study
Body glucose stores
Measured: Pre, mid and post study
Oxygen delivery
Measured: Pre, mid and post study
Acute mountain sickness
Measured: Every day
Spontaneous physical activity level
Measured: Pre, mid and post study
Rating of perceived exertion during a stepping task
Measured: Pre, mid and post study
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Aug 2008 (estimated)
- Study startJun 2008
- Primary completionOct 2008
- Study completionDec 2008
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for HypoxiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 44 participants (actual)
Sponsor and investigators
- Lead sponsor
- Medical Expeditions Ltd
- Sponsor type
- University, hospital or other
- Collaborators
- Bangor University, Science in Sport, Plans Branch of Headquarters Army Recruiting and Training Division
- Responsible party
- Sponsor
- Investigators
- Jamie H Macdonald, PhD, Principal investigator, Bangor UniversitySamuel J Oliver, PhD, Principal investigator, Bangor University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00731510
- Sponsor's protocol ID
- 08/WNo01/16
- Status last verified
- Mar 2017
- First submitted
- 7 Aug 2008
- Last updated
- 31 Mar 2017
- Results posted
- No
- Data monitoring committee
- No
Publications
Macdonald JH, Oliver SJ, Hillyer K, Sanders S, Smith Z, Williams C, Yates D, Ginnever H, Scanlon E, Roberts E, Murphy D, Lawley J, Chichester E. Body composition at high altitude: a randomized placebo-controlled trial of dietary carbohydrate supplementation. Am J Clin Nutr. 2009 Nov;90(5):1193-202. doi: 10.3945/ajcn.2009.28075. Epub 2009 Sep 30.
PubMed 19793859
Study at a glance
From the registry record, last updated by the sponsor on 31 Mar 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- MEDEX Hidden Valley 2008
- ClinicalTrials.gov ID
- NCT00731510
- Acronym / sponsor ID
- 08/WNo01/16
- Conditions
- Hypoxia
- Keywords
- Acute mountain sickness, Body composition,Hypoxia, Carbohydrate supplementation, Expedition,, Hydration,, Hypoxia, Performance
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 44 participants (actual)
- Lead sponsor
- Medical Expeditions LtdUniversity, hospital or other
- Collaborators
- Bangor University, Science in Sport, Plans Branch of Headquarters Army Recruiting and Training Division
- Study start
- Jun 2008
- Primary completion
- Oct 2008 (actual)
- Study completion
- Dec 2008 (actual)
- First posted
- 11 Aug 2008 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
During a multi-week expedition to the Himalaya, we aim to investigate i) whether dietary supplementation with carbohydrate drinks and gels can improve physical performance; and ii) the underlying mechanisms for any observed changes in performance.
We hypothesise that i) carbohydrate supplementation will improve physical performance; and ii) the underlying mechanism of this improvement in performance will include maintenance of body glycogen (sugar) stores, prevention of dehydration and decrease in the incidence of acute mountain sickness.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| 1 | Experimental | Dietary Supplement: Carbohydrate energy drinkCarbohydrate supplements (drinks and gels) |
| 2 | Placebo comparator | Dietary Supplement: AspartamePrimarily Aspartame plus natural flavourings. Powder dissolved in water to provide non-distinguishable placebo drink. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- a healthy enthusiasm for the outdoors and/or a passion for research in remote and difficult circumstances
Key exclusion criteria (1 listed)
- Persons with Phenylketonuria
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Carbohydrate energy drinkAlso: PSP22 Energy, Science in Sport, Blackburn, UKComplex carbohydrates including maltodextrin (97%) dissolved in water to make a a 10% solution, or dissolved in 25mL gels. Ad libitum. Twenty two days. | Dietary supplement | 1 |
| AspartameAlso: Science in Sport, Blackburn, UKAspartame dissolved in water, ad libitum, 22 days. | Dietary supplement | 2 |
Primary outcome
Performance (time to complete a physical performance task)
Time frame: Mid study
7 secondary outcomes
Body composition
Time frame: Pre, mid and post study
Hydration status
Time frame: Pre, mid and post study
Body glucose stores
Time frame: Pre, mid and post study
Oxygen delivery
Time frame: Pre, mid and post study
Acute mountain sickness
Time frame: Every day
Spontaneous physical activity level
Time frame: Pre, mid and post study
Rating of perceived exertion during a stepping task
Time frame: Pre, mid and post study
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Mar 2017.
- Derived from this study: PubMed 19793859Macdonald JH, Oliver SJ, Hillyer K, Sanders S, Smith Z, Williams C, Yates D, Ginnever H, Scanlon E, Roberts E, Murphy D, Lawley J, Chichester E. Body composition at high altitude: a randomized placebo-controlled trial of dietary carbohydrate supplementation. Am J Clin Nutr. 2009 Nov;90(5):1193-202. doi: 10.3945/ajcn.2009.28075. Epub 2009 Sep 30.
Related trials for Hypoxia
Active, not recruitingPhase 1/2
A Study of Belzutifan (MK-6482) in Combination With Palbociclib Versus Belzutifan Monotherapy in Participants With Advanced Renal Cell Carcinoma (MK-6482-024/LITESPARK-024)
Renal Cell Carcinoma
Not yet recruiting
Levetiracetam as an Adjuvant Therapy to Hypothermia in Neonatal Asphyxia
Hypoxic Ischemic Encephalopathy of Newborn, Neuro-protection
RecruitingPhase 1/2
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
Renal Cell Carcinoma
Recruiting
Minimal Sedation Versus Standard Continuous Sedation After Out-of-Hospital Cardiac Arrest
Out-of-Hospital Cardiac Arrest, Hypoxic-Ischemic Brain Injury
Recruiting
Ventilator Pressure and Optimization of Compliance and Hemodynamics
Bronchopulmonary Dysplasia, Pulmonary Hypertension Due to Lung Diseases and Hypoxia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jamie H Macdonald, PhD principal investigator
Bangor University
Samuel J Oliver, PhD principal investigator
Bangor University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Carbohydrate energy drink and Aspartame in people with Hypoxia, run by Medical Expeditions Ltd at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 31 Mar 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Performance (time to complete a physical performance task) (time frame: Mid study). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00731510, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Mar 2017.